In mid-November, Baack wrote a $15,830.30 check to satisfy the property taxes on his 76-year-old home in southwest Portland.

Separately, upon receipt of the full efficacy and safety results for the NORSE EIGHT clinical trial in the United States, which are expected in January 2025, Outlook Therapeutics plans to resubmit its ...

Obstructive sleep apnea (OSA) was linked to a more than twofold risk of developing age-related macular degeneration (AMD) in ...

Dr. Piccione completed an internship program at the Randall VA Medical Center in Gainesville, where he trained extensively in ...

Algae oil comes from marine algae that’s rich in omega-3s. The oil has many uses, from cooking to skincare and condition ...

Roche (RHHBY) announced that the European Medicines Agency, EMA, has approved Vabysmo 6.0 mg single-dose prefilled syringe, PFS, for use in the ...

Advanced tools are being deployed by Duke Health and others in the fight against vision loss. STORY HIGHLIGHTS Half of ...

(RTTNews) - Roche (RHHBY) announced that the European Medicines Agency has approved Vabysmo or faricimab, 6.0 mg single-dose prefilled syringe for use in the treatment of neovascular or 'wet' ...

Keeping a sharp eye on geographic atrophy (GA) associated with age-related macular degeneration is the goal and reaching it ...

EXG102 and EXG202 are investigational gene therapy candidates for wet age-related macular degeneration that are in ...

EXG102 and EXG202 are investigational gene therapy candidates for wet age-related macular degeneration that are in ...

These modalities produce considerable visual data, crucial for identifying and monitoring ocular diseases such as age-related macular degeneration, diabetic retinopathy, and glaucoma. Although ...